Lambersart, France

Christophe De Romeuf

USPTO Granted Patents = 30 

 

 

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 120(Granted Patents)


Location History:

  • Lille, FR (2009 - 2018)
  • Lambersart, FR (2009 - 2023)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
30 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Christophe De Romeuf in Immunotherapy

Introduction

Christophe De Romeuf, based in Lambersart, France, is an accomplished inventor renowned for his contributions to the field of immunotherapy. With an impressive portfolio of 29 patents, De Romeuf has made significant strides in enhancing therapeutic approaches for autoimmune and inflammatory diseases.

Latest Patents

Among his latest innovations are two notable patents that demonstrate his expertise. The first patent focuses on the "Use of modified Fc fragments in immunotherapy," exploring the application of isolated recombinant Fc fragments with modified affinity to Fc receptors (FcR). These advancements hold promise for the effective treatment of autoimmune and inflammatory conditions. His second patent, titled "Fc mutants with modified functional activity," introduces polypeptides with mutated Fc regions exhibiting altered functional activities. This innovation involves specific combinations of mutations that enhance the polypeptide's capabilities, offering valuable insights for further therapeutic developments.

Career Highlights

Christophe De Romeuf's professional journey includes significant roles at leading biotechnology companies, including Laboratoire Français Du Fractionnement Et Des Biotechnologies and LFB Biotechnologies. His tenure at these organizations has allowed him to contribute to groundbreaking research and development in immunotherapeutic solutions.

Collaborations

Throughout his career, De Romeuf has collaborated with esteemed colleagues, including Dominique Bourel and Nicolas Bihoreau. These partnerships have enriched his research endeavors, fostering a collaborative environment that encourages innovation and discovery in the biotechnology sector.

Conclusion

In summary, Christophe De Romeuf stands out as a prolific inventor whose work in immunotherapy has the potential to revolutionize treatment strategies for autoimmune and inflammatory diseases. His impressive array of patents reflects a commitment to enhancing patient outcomes through innovative approaches, solidifying his legacy in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…